LICN:NASDAQLichen International Limited Analysis
Data as of 2026-06-11 - not real-time
Latest Price
Risk Level: High
Executive Summary
Lichen International Limited trades at $2.62, modestly above its 20‑day SMA of $2.34 but well below the 50‑day ($4.15) and 200‑day ($3.78) averages, indicating a neutral price trend. The RSI sits at 47, suggesting neither overbought nor oversold conditions, while the MACD histogram is positive, giving a brief bullish signal despite a negative MACD line. Volatility is extreme at roughly 398% over the past 30 days, and the stock has endured a historic max drawdown of about -90%, underscoring severe price swings. Fundamentally, revenue plunged 56% year‑over‑year to $24.5 M and both operating and net margins are deeply negative (‑89% and ‑90% respectively), with EBITDA and cash flow also in the red. The balance sheet shows $26.9 M of cash versus only $0.55 M of debt, yielding a low debt‑to‑equity ratio but the company is burning cash at a high rate. Valuation metrics reflect a price‑to‑book of 0.61, hinting at potential asset‑value upside, yet the lack of earnings renders PE ratios meaningless. No dividend is paid, making dividend sustainability a non‑issue. The business operates in China’s specialty business‑services sector, exposing it to regulatory and geopolitical headwinds. Overall, the stock’s technical picture is mixed, but the overwhelming negative earnings trajectory and extreme volatility dominate the outlook.
Market Outlook
Short Term
< 1 yearKey Factors
- Negative earnings and large cash burn
- Revenue decline of over 50% YoY
- Extreme price volatility and recent max drawdown
Medium Term
1–3 yearsKey Factors
- Low price‑to‑book suggests asset value cushion
- Strong cash position relative to minimal debt
- Uncertainty around turnaround of operating performance
Long Term
> 3 yearsKey Factors
- Potential upside if the company restructures and restores profitability
- Undervalued balance‑sheet metrics provide margin of safety
- Long‑term growth of China’s service sector could benefit the business
Key Metrics & Analysis
Financial Health
Technical Analysis
Valuation
Risk Assessment
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.